Regulation of p38 mitogen-activated protein kinase during NK cell activation
- 1 October 2000
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 30 (10) , 2791-2798
- https://doi.org/10.1002/1521-4141(200010)30:10<2791::aid-immu2791>3.0.co;2-d
Abstract
The mitogen‐activated protein kinase (MAPK) p38 modulates a variety of cellular functions, including proliferation, differentiation and cell death. However, we report here a novel function for p38, i. e. the regulation of cytotoxic lymphocyte‐mediated cytotoxicity. Stimulation of NK cells by either cross‐linking of their FcγRIII receptors or by binding to NK‐sensitive target cells induces the phosphorylation and activation of p38, and also of its upstream regulators MKK3 / MKK6. Pharmacologic analyses suggest that Src‐family and Syk‐family protein tyrosine kinases couple the NK cell surface receptors to p38 activation. The role of p38 in the cytotoxic function of NK cells was tested by treatment of NK cells with the cell‐permeable, p38‐specific inhibitor SB203580. Interestingly, exposure to the drug reduced both antibody‐dependent cellular cytotoxicity and natural cytotoxicity, but maximal inhibitory concentrations resulted in only partial inhibition. Collectively, these results suggest that the p38 MAPK pathway is stimulated during the development of NK cell‐mediated cytotoxicity and that efficient killing is influenced by both p38‐dependent and p38‐independent pathways. More broadly, this study identifies the regulation of cell‐mediated killing as a novel role for p38 in cytotoxic lymphocytes.Keywords
This publication has 37 references indexed in Scilit:
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- A Specific Inhibitor of the p38 Mitogen Activated Protein Kinase Affects Differentially the Production of Various Cytokines by Activated Human T Cells: Dependence on CD28 Signaling and Preferential Inhibition of IL-10 ProductionCellular Immunology, 1999
- The Vav–Rac1 Pathway in Cytotoxic Lymphocytes Regulates the Generation of Cell-mediated KillingThe Journal of Experimental Medicine, 1998
- Functional Role for Syk Tyrosine Kinase in Natural Killer Cell–mediated Natural CytotoxicityThe Journal of Experimental Medicine, 1997
- Allo‐skin graft rejection, tumor rejection and natural killer activity in mice lacking p56lckEuropean Journal of Immunology, 1995
- Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity.The Journal of Experimental Medicine, 1994
- Association of the p56lck protein tyrosine kinase with the FCγRIIIA/CD16 complex in human natural killer cellsEuropean Journal of Immunology, 1993
- Association of a 70‐kDa tyrosine phosphoprotein with the CD16:ζ:γ complex expressed in human natural killer cellsEuropean Journal of Immunology, 1993
- Physical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells.The Journal of Experimental Medicine, 1993
- Profound block in thymocyte development in mice lacking p56lckNature, 1992